Age: 68.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Light post nasal drainage; Day 3, itching has progressed with large area of redness extending from the deltoid injection site widely over the biceps to approximately 2 inches above antecubital space; Day 2 site simultaneously tender and itching; Significant dry cough; Runny nose; Day1 cold chills; Malaise; Tenderness at injection site; This is a spontaneous report received from a Nurse.  A 68-year-old female patient (not pregnant) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 06Sep2024 at 10:00 as dose 1, single (Batch/Lot number: unknown) at the age of 68 years, in right deltoid for covid-19 immunisation; influenza vaccine inact split 3v (FLUZONE HIGH DOSE), on 06Sep2024 as dose number unknown, single (triv 2024-25) (Lot number: NDC49281-0124-65), in right arm for immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Autoimmune HLAB27 + Arthritis" (unspecified if ongoing); "S/P Thyroidectomy" (unspecified if ongoing); "GERD" (unspecified if ongoing); "Seasonal Allergies" (unspecified if ongoing); "Penicillin allergy" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; LEVOTHYROXINE; CRESTOR; MAGNESIUM CITRATE; CALCIUM CARBONATE; VIT D3; CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTUERE UNKNOWN), for COVID-19 immunization, reaction(s): "cold chills", "Malaise"; Covid-19 vaccine (DOSE 2; MANUFACTUERE UNKNOWN), for COVID-19 immunization, reaction(s): "cold chills", "malaise"; Covid-19 vaccine (DOSE 3 (BOOSTER); MANUFACTUERE UNKNOWN), for COVID-19 immunization, reaction(s): "cold chills", "Malaise"; Covid-19 vaccine (DOSE 4 (BOOSTER); MANUFACTUERE UNKNOWN), for COVID-19 immunization, reaction(s): "cold chills", "Malaise"; Covid-19 vaccine (DOSE 5 (BOOSTER); MANUFACTUERE UNKNOWN), for COVID-19 immunization, reaction(s): "cold chills", "Malaise"; Covid-19 vaccine (DOSE 6 (BOOSTER); MANUFACTUERE UNKNOWN), for COVID-19 immunization, reaction(s): "cold chills", "Malaise"; Covid-19 vaccine (DOSE 7 (BOOSTER); MANUFACTUERE UNKNOWN), for COVID-19 immunization, reaction(s): "cold chills", "Malaise". The following information was reported: CHILLS (non-serious) with onset 06Sep2024, outcome "recovered" (Sep2024), described as "Day1 cold chills"; MALAISE (non-serious) with onset 06Sep2024, outcome "recovering"; RHINORRHOEA (non-serious) with onset 06Sep2024, outcome "recovering", described as "Runny nose"; COUGH (non-serious) with onset 06Sep2024, outcome "recovered" (Sep2024), described as "Significant dry cough"; VACCINATION SITE PAIN (non-serious) with onset 06Sep2024, outcome "recovering", described as "Tenderness at injection site"; VACCINATION SITE PRURITUS (non-serious) with onset 07Sep2024, outcome "recovering", described as "Day 2 site simultaneously tender and itching"; VACCINATION SITE ERYTHEMA (non-serious) with onset 08Sep2024, outcome "recovering", described as "Day 3, itching has progressed with large area of redness extending from the deltoid injection site widely over the biceps to approximately 2 inches above antecubital space"; UPPER-AIRWAY COUGH SYNDROME (non-serious) with onset 08Sep2024, outcome "recovering", described as "Light post nasal drainage". Therapeutic measures were taken as a result of cough. Therapeutic measures were not taken as a result of rhinorrhoea, upper-airway cough syndrome, chills, malaise, vaccination site pain, vaccination site pruritus, vaccination site erythema.  Additional information: The patient had received the vaccine on 06Sep2024 at 10:00 am. Day1 cold chills and malaise which occurred with all of my Covid vaccines. At the 12-14 hr mark post vaccination, began with significant dry cough and runny nose. Utilized Albuterol inhaler and Delsym. Tenderness at injection site. Day 2 site simultaneously tender and itching. Today, day 3, itching has progressed with large area of redness extending from the deltoid injection site widely over the biceps to approximately 2 inches above antecubital space. Cough is gone, chills gone. Light post nasal drainage. the patient did not received any other vaccines within 4 weeks prior to the vaccine(s) for which you are reporting. The patient was taking other medications within 2 weeks of the event starting.